Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The British Society of Gastroenterology (BSG) and the Association of Coloproctology for Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The aim, as before, is to provide guidance on the appropriateness, method and frequency of screening for people at moderate and high risk from colorectal cancer. This guidance provides some new recommendations for those with inflammatory bowel disease and for those at moderate risk resulting from a family history of colorectal cancer. In other areas guidance is relatively unchanged, but the recent literature was reviewed and is included where appropriate.

Original publication




Journal article



Publication Date





666 - 689


Digestive Diseases Centre, Brighton and Sussex University Hospitals, Royal Sussex County Hospital, Eastern Road, Brighton, UK.


British Society of Gastroenterology, Association of Coloproctology for Great Britain and Ireland, Colon, Sigmoid, Ureter, Humans, Adenoma, Colorectal Neoplasms, Neoplastic Syndromes, Hereditary, Acromegaly, Inflammatory Bowel Diseases, Colonoscopy, Anastomosis, Surgical, Population Surveillance, Evidence-Based Medicine, State Medicine, Early Detection of Cancer